|
|
|
Company Name
|
Impax Laboratories Inc
|
|
Drug Name
|
IPX066 or Rytary (NDA)
|
|
Event Name
|
FDA decision on Rytary for treatment of idiopathic Parkinson's disease
|
|
Event Date
|
10/21/2012
|
|
Outcome
|
FDA decision date postponed to January 21, 2013
|
|
Drug Status
|
|
|
Rival Drugs
|
|
|
Market Potential
|
|
|
Other Approvals
|
|
|
News |
|
|
|
Return to FDA Calendar
|